Arax Advisory Partners
SLDB icon

Arax Advisory Partners’s Solid Biosciences SLDB Stock Holding History

Arax Advisory Partners’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51K Buy
+5,107
New +$38.7K ﹤0.01% 3247
2025
Q4 		– Sell
-9,200
Closed -$56.8K – 4487
2025
Q3 		$56.8K Buy
+9,200
New +$53.8K ﹤0.01% 1773

Other funds holding SLDB

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arax Advisory Partners's SLDB Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Solid Biosciences (SLDB) in Q2 2026: 5,107 shares worth $51K. The stake represents ﹤0.01% of the portfolio and ranks #3247 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SLDB as recently as Q3 2025.

Arax Advisory Partners first reported a position in SLDB in Q3 2025 and has held it in 2 quarters since. The position peaked at $56.8K in Q3 2025. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Arax Advisory Partners held 5,107 shares of Solid Biosciences worth $51K as of Q2 2026.
  • Solid Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3247 holding.
  • Arax Advisory Partners first reported a position in Solid Biosciences in Q3 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's Solid Biosciences position peaked at $56.8K in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.